CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations
- 13 August 2025
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 26 (10-12) , 367-376
Abstract
Cytochrome P450 2D6 (CYP2D6) is a highly polymorphic enzyme responsible for metabolizing approximately 20% of commonly prescribed drugs. Its genetic variability contributes to interindividual and interethnic differences in drug response. However, large-scale studies on CYP2D6 allele distributions in the Korean population remain limited. We conducted CYP2D6 genotyping, including copy number variation analysis, in 3,874 unrelated Korean individuals recruited from five university hospitals. Genotypes were assigned diplotypes and phenotypes using the CPIC activity score system. The most frequent allele was the decreased-function *10 (44.9%), followed by normal-function *1 (32.8%) and 2 (11.0%). The gene deletion five accounted for 5.7%. Among phenotypes, 62.2% were extensive metabolizers, 36.1% intermediate metabolizers, 0.9% ultrarapid metabolizers, and 0.4% poor metabolizers. We also identified CYP2D6 × 65, previously unreported in Koreans, and a novel duplication variant, CYP2D6 × 49x2. This is the largest study of CYP2D6 polymorphisms in a Korean population to date. It provides a comprehensive reference for Korean pharmacogenomics and highlights important interethnic differences. The findings support the development of personalized medicine strategies based on population-specific pharmacogenetic data.Keywords
This publication has 24 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker TherapyClinical Pharmacology & Therapeutics, 2024
- Recommendations for Clinical CYP2D6 Genotyping Allele SelectionThe Journal of Molecular Diagnostics, 2021
- Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene VariationClinical Pharmacology & Therapeutics, 2021
- Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016Clinical Pharmacokinetics, 2019
- Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic ResearchClinical Pharmacology & Therapeutics, 2018
- CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypesArchives of Pharmacal Research, 2018
- Prediction of CYP2D6 phenotype from genotype across world populationsGenetics in Medicine, 2017
- Robust CYP2D6 genotype assay including copy number variation using multiplex single-base extension for Asian populationsClinica Chimica Acta, 2010
- The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangementsEuropean Journal of Clinical Pharmacology, 2008
- Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspectsPharmacology & Therapeutics, 2007